Shawn Kwatra, MD, and Peter Lio, MD, FAAD, discuss the burden of atopic dermatitis (AD) and how it may affect pediatric or adult patients.
The Power of Topical Creams: Combining BSA and Itch Data for Effective Atopic Dermatitis Management
Experts discuss the symptoms of atopic dermatitis (AD) and how disease severity may impact symptoms.
Peter Lio, MD, FAAD, and Shawn Kwatra, MD, discuss janus kinase (JAK) inhibitors and their recent use in the treatment of atopic dermatitis (AD).
Experts discuss the history and evolving landscape of topical steroids as therapy for atopic dermatitis (AD).
Shawn Kwatra, MD, offers important considerations for providers when utilizing topical therapies for atopic dermatitis (AD).
Peter Lio, MD, FAAD, discusses how body surface area of atopic dermatitis (AD) affects topical treatment options.
In a Dermatology Times DermView custom video series, Shawn Kwatra, MD, and Peter Lio, MD, discuss the topical treatment landscape of atopic dermatitis.
Experts offer their clinical experience on preventing patient withdrawal and breaking the atopic dermatitis (AD) disease cycle.
Experts discuss prospective therapies on the horizon for atopic dermatitis (AD).
Advertisement
Advertisement
Trending on Dermatology Times
1
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
2
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
3
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
4
Phase 2 Trial Supports Oral VDPHL01 for Female Pattern Hair Loss
5